ROSEL-T 50/3/300MG 24 TAB LGEN CSLBEHRING Tratamiento de rinosinusitis crónica con

Description

Tratamiento de rinosinusitis crónica con poliposis nasal

Náuseas o malestar gastrointestinal

CIMZIA® es un medicamento biológico cuyo principio activo es el certolizumab pegol

Caja con 1 frasco ámpula de 50 mg de Oxaliplatino

ROSEL-T 50/3/300MG 24 TAB LGEN CSLBEHRING Tratamiento de rinosinusitis crónica conPRINCIPIO ACTIVO: AMANTADINA, CLORFENAMINA, PARACETAMOL

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy